Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts LaFleur Minerals Inc. Location, Mill Creates Strategic Advantage in Ongoing Gold Rally June 26, 2025 RUA GOLD Closes C$13.8 Million Brokered Offering Including the Full Exercise of Over-Allotment Option June 26, 2025 Carbonxt Increases Stake in Kentucky Facility June 26, 2025
RUA GOLD Closes C$13.8 Million Brokered Offering Including the Full Exercise of Over-Allotment Option June 26, 2025